5-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors
US12258327B2 · kind B2 · utility
0Cited by
9References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 26, 2022 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Aug 26, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided are 5-membered heteroaryl-containing aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.